Your gateway to the world of medicine
Cancer News
About Us
Health Professionals
Patients and public
Contact Us

From Genes found in most breast cancers could be vaccination targets

Breast cancer main Chemotherapy Mammogram  

Genes found in most breast cancers could be vaccination targets

Increasing number of genes are actively sought and discovered in a never-ending fight to defeat breast cancer. Many new target genes are discovered every year and more and more treatment options are in pipeline based on these newly identified target genes or gene products.

A gene that appears to help regulate normal embryonic development is found at high levels in virtually all forms of breast cancer, according to a new study led by Laszlo Radvanyi, Ph.D., associate professor of breast and melanoma medical oncology at The University of Texas M. D. Anderson Cancer Center.

The finding, published in a recent issue of the Proceedings of the National Academy of Sciences and, shows that the gene, normally made in small amounts in normal breast tissue, somehow becomes over-expressed in breast cancer cells. Researchers hope to use the cancer-specific protein to train the immune system to specifically attack breast cancer cells.

"There is a tremendous need for new molecular targets to treat breast cancer," Radvanyi says. "There are very few bona fide targets that are exquisitely specific for breast cancer. We believe this is one of them."

Radvanyi and his collaborators at Sanofi Pasteur, Toronto, Canada, zeroed in on the gene, called TRPS-1, after an exhaustive search for targets that are found at higher levels in breast cancer than in normal tissue. The researchers compared the gene levels of more than 50,000 known genes in 54 breast cancer specimens and 289 normal samples representing 75 tissues or organs. The breast cancer specimens included 10 examples of early breast cancer or ductal carcinoma in situ (DCIS), 38 locally invasive breast cancers and six representing metastatic disease. They narrowed down their search by eliminating genes commonly found in normal tissue and those predicted to encode proteins that are excreted from the cell.

"We were interested in identifying proteins that could be potential tumor antigens activating cytotoxic T-cells or tumor killer cells," Radvanyi says. "We wanted proteins that would make good targets for a cancer vaccine."

Finally, they zeroed in on TRPS-1, a gene they found at high levels in all forms of breast cancer, from DCIS to invasive disease, but in none of the normal tissues tested, except for low levels found in normal breast tissue.

The TRPS-1 gene turned out to be associated with a rare, inherited genetic disease in which loss of the gene function results in muscle and bone deformities. The gene is located on human chromosome 8 in a region previously known to be associated with breast cancer and other oncogenes. The scientists don't yet know what the TRPS-1 protein is doing during the development of breast cancer, but they have started gathering clues to its role. Scientists at other institutions have shown TRPS-1 is a DNA-binding protein that regulates how other proteins get produced. It also appears to be involved in recognition of steroids such as estrogen. Radvanyi speculates that the protein may help regulate cell growth and perhaps estrogen recognition.

"Based on our findings, we believe that TRPS-1 is involved in the earliest stages of breast cancer," he says.

The success of the breast cancer drug Herceptin, an antibody that specifically attacks breast cancer cells in which the Her2/neu gene is active, has made immunotherapy an attractive option for treating breast cancer. However, only about one-third of breast cancer patients are candidates for Herceptin treatment. Radvanyi's technique does not use antibodies, but instead attempts to get powerful immune system cells called T-cells to attack the cancer cells.

Once they had identified TRPS-1, the researchers wanted to test its ability to act as an antigen, a protein that could prime the immune system to attack breast cancer cells. They used portions of the TRPS-1 protein as antigens to train human T-cells to attack cells containing TRPS-1. T-cells are white blood cells of the immune system that recognize and destroy bacteria, viruses and other foreign tissue. The scientists showed T-cells trained to detect TRPS-1 would attack and kill breast cancer cells containing the protein in laboratory experiments.

"This is exciting because TRPS-1 appears to be over-expressed only in cancers and not in normal tissue," Radvanyi says. "This makes it much less likely that normal tissue would be attacked in an immunotherapy setting."

The researchers' next steps will be to test more patient samples at M. D. Anderson and try to correlate levels of TRPS-1 to other known breast cancer markers, such as HER2/neu and the estrogen receptor. They also want to understand what the protein's targets are inside the cell.

"If we understand its targets, we might be able to design inhibitors that disrupt its action, which could be clinically important given its early appearance in breast cancer," Radvanyi says.

This story is adapted from a press release from MD Anderson Cancer Center

Did you know? In the year 2005, a total of 211,240 women would be diagnosed with breast cancer in the United States. Genes found in most breast cancers could be vaccination targets

Alzheimer's disease dementia more in women| Antibody to fight breast cancer| Aspirin or vitamin e does not prevent cancer| Benign breast disease and breast cancer| Breast cancer prognosis not worse in males| Breast cancer screening without breast compression| Cancer fighting drugs from pineapple| Chemosensitvity testing in cancer| Chmotherapy for breast and risk of leukemia| Computer program to diagnose breast cancer on mammograms| Decline in physical activity leads to weight gain among adolescent girls| Diuretics use in people with diabetes and high blood pressure| Does mammogram improve survival| Exercise after chemotherapy restores immune function| Gene causing lung spread of breast cancer identified| High blood pressure not well controlled among older men and women| Higher breast cancer death rates among educated women| Higher insulin levels may be related to impaired cognition in women| Hope for more targeted therapies in breast cancer| Hormone replacement therapy hrt stopping may cause symptoms| Hormone vaccine combo effective in hormone resistant prostate cancer| Increased risk of stroke in childhood cancer and leukemia survivors| Inflammatory breast cancer on the rise| Insight in to the breast cancer growth mechanism| Liquid embolic system receives fda approval| Lung cancer prevention trial re activated| New approach to brain surgery | Possible location of lung cancer genes| Repeat colonoscopy screening after 3 years| Screening colonoscopy detects more colon cancers in males| Sleeping beauty and cancer genes| Sorafenib doubles survival in renal cell cancer| Stat3 protein and stomach cancer| Switching tamoxifen to anastrozole| Taxotere plus herceptin improves survival| Teach your children to eat healthier diet| Trail 2 expression associated with breast cancer survival| Treat breast cancer and preserve fertility| Use sunscreen to lower the risk of skin cancer| Utility of psa values questioned| Value and utility of virtual colonscopy colonography| Why do we still have high rates of cervical cancer| Women and colonoscopy screening|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.